[HTML][HTML] Role of m6A writers, erasers and readers in cancer

Z Fang, W Mei, C Qu, J Lu, L Shang, F Cao… - … Hematology & Oncology, 2022 - Springer
Abstract The N (6)-methyladenosine (m6A) modification is the most pervasive modification of
human RNAs. In recent years, an increasing number of studies have suggested that m6A …

[HTML][HTML] Fusobacterium nucleatum and oral cancer: a critical review

E McIlvanna, GJ Linden, SG Craig, FT Lundy… - BMC cancer, 2021 - Springer
There is a growing level of interest in the potential role inflammation has on the initiation and
progression of malignancy. Notable examples include Helicobacter pylori-mediated …

Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: updated results of the phase III KEYNOTE-048 study

KJ Harrington, B Burtness, R Greil… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE Pembrolizumab and pembrolizumab-chemotherapy demonstrated efficacy in
recurrent/metastatic head and neck squamous cell carcinoma in KEYNOTE-048. Post hoc …

Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and …

NY Lee, RL Ferris, A Psyrri, RI Haddad… - The Lancet …, 2021 - thelancet.com
Background Chemoradiotherapy is the standard of care for unresected locally advanced
squamous cell carcinoma of the head and neck. We aimed to assess if addition of avelumab …

[HTML][HTML] Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing

CHL Kürten, A Kulkarni, AR Cillo, PM Santos… - Nature …, 2021 - nature.com
Head and neck squamous cell carcinoma (HNSCC) is characterized by complex relations
between stromal, epithelial, and immune cells within the tumor microenvironment (TME). To …

Nivolumab plus ipilimumab versus EXTREME regimen as first-line treatment for recurrent/metastatic squamous cell carcinoma of the head and neck: the final results of …

RI Haddad, K Harrington, M Tahara… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE CheckMate 651 (ClinicalTrials. gov identifier: NCT02741570) evaluated first-line
nivolumab plus ipilimumab versus EXTREME (cetuximab plus cisplatin/carboplatin plus …

Soft robotic manipulator for intraoperative MRI-guided transoral laser microsurgery

G Fang, MCK Chow, JDL Ho, Z He, K Wang, TC Ng… - Science Robotics, 2021 - science.org
Magnetic resonance (MR) imaging (MRI) provides compelling features for the guidance of
interventional procedures, including high-contrast soft tissue imaging, detailed visualization …

[HTML][HTML] Extricating human tumour immune alterations from tissue inflammation

F Mair, JR Erickson, M Frutoso, AJ Konecny, E Greene… - Nature, 2022 - nature.com
Immunotherapies have achieved remarkable successes in the treatment of cancer, but major
challenges remain,. An inherent weakness of current treatment approaches is that …

Salivary gland function, development, and regeneration

AM Chibly, MH Aure, VN Patel… - Physiological …, 2022 - journals.physiology.org
Salivary glands produce and secrete saliva, which is essential for maintaining oral health
and overall health. Understanding both the unique structure and physiological function of …

CD73 in small extracellular vesicles derived from HNSCC defines tumour‐associated immunosuppression mediated by macrophages in the microenvironment

T Lu, Z Zhang, J Zhang, X Pan, X Zhu… - Journal of …, 2022 - Wiley Online Library
Research on tumour cell‐derived small extracellular vesicles (sEVs) that regulate tumour
microenvironment (TME) has provided strategies for targeted therapy of head and neck …